Strategic Analysis Of Pfizer's Strategic Analysis

Pfizer is a global pharmaceutical and consumer products company, which discovers, develops, manufactures, and markets medicines for humans and animals. The company consists of three SBU's (Strategic Business Units):

Corporate governance can address agency problems, they are the rules that dictate the company’s behavior towards it’s directors, managers, employees, shareholders, creditors, competitors and community.

One primary goal of Pfizer is to deliver sustained, excellent product by outperforming Pfizer’s competitors and must differentiate itself adequately from its competitors. Competitive advantage is central to strategic management in that it will produce and sustain superior performance. To be competitive in a business environment, often it requires the company to have a product or service different and better than other organizations competing in the same marketplace. According to Wadman (2007) “Pfizer and the rest of the pharmaceutical industry need to develop more sophisticated drugs, targeted at a smaller number of people more quickly, efficiently and at a lower cost” (p. 1). Once Pfizer’s strengths, weaknesses, opportunities, and threats are assessed and analyzed, managers must decide a set of strategies to reduce or eliminate its weaknesses and capitalize on its strengths and maximize opportunities. An example is Porter’s three generic strategy approaches of differentiation, cost leadership, and focus strategy by using differentiation strategies to differentiate Pfizer from its competitors. Strategies are essential; however, it is useless unless they are effectively implemented levels of the company. Business-level strategies are typically developed and implemented by heads of business units and are first approved by top management. The functional level strategy is the last level that focuses on developing strategies for managing the various departments to

Pfizer is the largest American pharmaceutical company and one of the largest pharmaceutical companies in the world. It competes with Merck and Glaxo, and markets such well-known medications as Celebrex and Viagra. However, the pharmaceutical industry as a whole has undergone changes in recent years with significant consolidation taking place and with increased scrutiny regarding the ways in which drugs are developed, tested and marketed. In addition, recent controversies have erupted regarding Merck's drug Vioxx, and Pfizer has been the target of unwanted publicity regarding its painkiller Celebrex. This research considers the strategic position of Pfizer, including its strengths and weaknesses as well

Opportunities for Pfizer exist in two areas, first being the restructuring into a more lean and competitive organization and second is the penetration into emerging markets such as China and India who are now more able to purchase their products. With sales of approximately $50 billion per year, Pfizer has the opportunity to streamline its operations, cut costs, and add flexibility to the organization. If successful in this, they can better realize their profits and invest that money into future competitive products for the market.

The Pfizer case provides an introduction to external analysis. The case highlights the pharmaceutical industry, which has enjoyed extraordinary long-run profitability. The case also demonstrates how broad changes in broad environmental factors (i.e. demographics, technology, culture, etc.) have an impact on industry competition. The case is not especially complex, so it is not overwhelming as a first case.

The pharmaceutical industry includes companies that research, develop, market or distribute generic and branded drugs. The industry expanded during the 1980’s and drugs to treat heart disease and AIDS were prominent. Consumer demand for nutritional supplements and alternative medicine increased during the 1990’s with the Internet facilitating direct purchases of drugs. Advertising for direct consumption of pharmaceutical drugs became more prominent; pharmaceutical companies were criticized for over medicating personality or social problems.

Fourth, Pfizer must streamline the business processes in order to reduce costs and improve shareholder returns. The Economist Magazine mentions that all 110,000 Pfizer employees were recently sent a memo, written by the newly named CEO named Jeffrey Kindler, informing them that they all must "focus make good and strong decisions in order to reduce costs".

Strategic Management deals with identification of goals and objectives of a company by its top management and implementation of activities and processes to coordinate with the resource of the company with mission, vision and strategy of the overall company (Frigo and Anderson, 2012; pp. 51-68). This report is about the strategic management of the GlaxoSmithKline company ltd, one of the largest manufacturing companies in United Kingdom. GlaxoSmithKline company’s management strategy has been critically analyzed here through the company has become a large revenue earning company in the world. GlaxoSmithKline company ltd (GSK) is a British Multinational healthcare company which research and develop products in three primary fields such as Pharmaceuticals, Vaccines and Consumer Healthcare.

Pfizer is the largest American pharmaceutical company and one of the largest pharmaceutical companies in the world. It competes with Merck and Glaxo, and markets such well-known medications as Celebrex and Viagra. However, the pharmaceutical industry as a whole has undergone changes in recent years with significant consolidation taking place and with increased scrutiny regarding the ways in which drugs are developed, tested and marketed. In addition, recent controversies have erupted regarding Merck's drug Vioxx, and Pfizer has been the target of unwanted publicity regarding its painkiller Celebrex. This research considers the strategic position of Pfizer, including its strengths and weaknesses as well

Pfizer is one of the world 's major pharmaceutical companies, and the main one in the US market. Pfizer produces a wide range of pharmaceutical products for various medical sectors, including: cardiology, neurology and oncology. In addition, Pfizer produces basic consumer healthcare products that help consumers with their everyday healthcare issues.

The agency conflict refers to a problem in which there is a conflict of interest between the two parties involved. Regarding corporate finance, an agency conflict is when the managers of a firm make decisions motivated by self-interest rather than focusing on the interest of shareholders. Evidently, the interests of the manager and the shareholders may be different. Companies usually offer incentives such as rewards, compensation, and threatening to fire or take over, in order to make sure that managers are making decisions according to the best interest of shareholders.

The Pfizer organization expresses a strong culture and interest in the well-being of people, both inside the company and in the larger human community. The company’s understanding of its responsibilities of citizenship required it to remain loyal to its hometown community. In its embrace of a structured, organized, and planned environment, Pfizer reveals the often subtle impact of the judging work style preference. The company has evolved a remarkably decentralized divisional structure, with distinct but wholly owned subsidiaries producing some of its best-known products: McNeill Laboratories makes Tylenol, Ethicon makes surgical products, and

Pfizer is known as one of the first and one of the world’s largest Pharmaceutical company that was establish in 1849. It was founded by two cousins called Charles Pfizer and Charles F. Erhart in New York City. Pfizer was as a manufacturer for fine chemicals but because of the discovery that was made in 1950 which made the company the path towards becoming the research-based pharmaceutical that it is update. The product that was first produced was the palatable form of sautonin which was used to treat intestinal worm. The Headquarters of Pfizer is located in New York City, with its research headquarters in Groton, Connecticut, which is nowadays the top multinational corporation that is sold all over the world. It is ranked as the second in the US and Japan market, and Novartis in first place and Roche in third place. The Pfizer Inc. is consisted with a trademark that is called PFIZER. Because of Pfizer’s strategies, Pfizer

The paper is going to discuss the business strategy and the strategic moves of Pfizer in trying to buy AstraZeneca. In addition, the paper will broadly talk about the environment (PEST analysis), the industry (Porter analysis), and stakeholder influence and business idea concerning AstraZeneca. . It will also demonstrate how the capabilities/ resources and competencies of the company projects are evaluated using the SWOT analysis and the value chain. It will also show some options that are strategic which are available to the company with the motive.